Learn more about my approach as a board-certified family physician and aesthetic expert
[1] The prevalence of GLP-1 RAs is such that Jan Hatzius, chief economist at Goldman Sachs, predicted a 1% boost (amounting to several trillion dollars) in GDP if 60 million people take the medications by 2028
Semaglutide is an FDA-approved GLP-1 (glucagon-like peptide-1) receptor agonist that mimics the bodys naturally occurring satiety hormones
By promoting cellular health, KLOW supports your bodys overall vitality, making it a cornerstone of modern regenerative medicine and a powerful strategy for long-term wellness
Although the FDA does conduct some surveillance and inspections of these pharmacies, the day-to-day oversight happens at the state level, which means standards can vary from state to state
Our team at Kariya Pharmaceuticals has been exploring brain-penetrant GLP-1s for CNS disorders for more than a decade, and the EVOKE study reinforces an important principle, namely that achieving meaningful effects in brain diseases requires a drug that can reliably reach the brain